Pamidronate for Hypercalcemia in Critically Ill Surgical Patients
Hypercalcemia in critically ill surgical patients is associated with increased severity of illness. Over a period of four days, pamidronate reduced iCa levels at ~0.08 mmol/L/day and corrected 80% of the hypercalcemic patients; however, it may cause further renal dysfunction.
Authors
- James G. Tyburski
- Lisa Hall Zimmerman (ORCID: https://orcid.org/0000-0002-1064-178X)
- Heather Dolman
- Robert F. Wilson (ORCID: https://orcid.org/0000-0001-6906-8415)
- W. Britt Zimmerman
- Lori K. Howell
- Alfred E. Baylor
- Janie Faris
Institutions
- Wayne State University (US)
- Detroit Receiving Hospital (US)
- Beaumont Hospital, Royal Oak (US)
- Michigan State University (US)
Publication Details
- Journal
- Cureus
- Published
- 2024-11-03
- DOI
- https://doi.org/10.7759/cureus.72922
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00